These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1648919)

  • 21. Inactivation of H+,K+-ATPase by a K+-competitive photoaffinity inhibitor.
    Munson KB; Sachs G
    Biochemistry; 1988 May; 27(11):3932-8. PubMed ID: 2843221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substituted thieno[3,4-d]imidazoles, a novel group of H+/K(+)-ATPase inhibitors. Differentiation of their inhibition characteristics from those of omeprazole.
    Beil W; Staar U; Sewing KF
    Eur J Pharmacol; 1990 Oct; 187(3):455-67. PubMed ID: 1963594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of gastric H+,K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole.
    Wallmark B; Briving C; Fryklund J; Munson K; Jackson R; Mendlein J; Rabon E; Sachs G
    J Biol Chem; 1987 Feb; 262(5):2077-84. PubMed ID: 3029064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photoaffinity labeling of the lumenal K+ site of the gastric (H+ + K+)-ATPase.
    Keeling DJ; Fallowfield C; Lawrie KM; Saunders D; Richardson S; Ife RJ
    J Biol Chem; 1989 Apr; 264(10):5552-8. PubMed ID: 2925619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soraprazan: setting new standards in inhibition of gastric acid secretion.
    Simon WA; Herrmann M; Klein T; Shin JM; Huber R; Senn-Bilfinger J; Postius S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):866-74. PubMed ID: 17369284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oleic acid as an inhibitor of gastric H+, K(+)-ATPase.
    Murakami S; Muramatsu M; Otomo S
    Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):337-50. PubMed ID: 1646470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversible and potent uncoupling of hog gastric (H(+)+K(+))-ATPase by prodigiosins.
    Matsuya H; Okamoto M; Ochi T; Nishikawa A; Shimizu S; Kataoka T; Nagai K; Wasserman HH; Ohkuma S
    Biochem Pharmacol; 2000 Dec; 60(12):1855-63. PubMed ID: 11108801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omeprazole, a specific inhibitor of gastric (H+-K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups.
    Im WB; Sih JC; Blakeman DP; McGrath JP
    J Biol Chem; 1985 Apr; 260(8):4591-7. PubMed ID: 2985559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of gastric H+,K(+)-ATPase by the anti-ulcer agent, sofalcone.
    Murakami S; Muramatsu M; Aihara H; Otomo S
    Biochem Pharmacol; 1991 Sep; 42(7):1447-51. PubMed ID: 1656986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.
    Mattsson JP; Väänänen K; Wallmark B; Lorentzon P
    Biochim Biophys Acta; 1991 Jun; 1065(2):261-8. PubMed ID: 1647821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of the K+-competitive H+,K+-ATPase inhibitor AZD0865 in isolated rat gastric glands.
    Kirchhoff P; Andersson K; Socrates T; Sidani S; Kosiek O; Geibel JP
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G838-43. PubMed ID: 16798725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Properties of light and heavy vesicles simultaneously prepared from hog gastric mucosae.
    Asano S; Iino T; Tabuchi Y; Takeguchi N
    J Biochem; 1988 Apr; 103(4):672-7. PubMed ID: 2844740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible inhibitions of gastric H+,K(+)-ATPase by scopadulcic acid B and diacetyl scopadol. New biochemical tools of H+,K(+)-ATPase.
    Asano S; Mizutani M; Hayashi T; Morita N; Takeguchi N
    J Biol Chem; 1990 Dec; 265(36):22167-73. PubMed ID: 2176205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of the acid pump in the stomach. Proton transport and hydrolysis of ATP and p-nitrophenyl phosphate by the gastric H,K-ATPase.
    Ljungström M; Mårdh S
    J Biol Chem; 1985 May; 260(9):5440-4. PubMed ID: 2985593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The specificity of omeprazole as an (H+ + K+)-ATPase inhibitor depends upon the means of its activation.
    Keeling DJ; Fallowfield C; Underwood AH
    Biochem Pharmacol; 1987 Feb; 36(3):339-44. PubMed ID: 3028428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of (H+ + K+)-ATPase by omeprazole in isolated gastric vesicles requires proton transport.
    Lorentzon P; Jackson R; Wallmark B; Sachs G
    Biochim Biophys Acta; 1987 Feb; 897(1):41-51. PubMed ID: 3026477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversible inhibitors of the gastric (H+/K+)-ATPase. 2. 1-Arylpyrrolo[3,2-c]quinolines: effect of the 4-substituent.
    Leach CA; Brown TH; Ife RJ; Keeling DJ; Laing SM; Parsons ME; Price CA; Wiggall KJ
    J Med Chem; 1992 May; 35(10):1845-52. PubMed ID: 1316968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium ions as substitutes for protons in the gastric H,K-ATPase.
    Polvani C; Sachs G; Blostein R
    J Biol Chem; 1989 Oct; 264(30):17854-9. PubMed ID: 2553694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the gastric (H+ + K+)-ATPase by fenoctimine.
    Reenstra WW; Shortridge B; Forte JG
    Biochem Pharmacol; 1985 Jul; 34(13):2331-4. PubMed ID: 2990481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on the inhibitory action of leminoprazole against rabbit gastric H+,K(+)-ATPase].
    Masuda M; Uchida A; Matsukura H; Kamishiro T
    Nihon Yakurigaku Zasshi; 1994 Oct; 104(4):325-35. PubMed ID: 7959423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.